Alimetrix
UEI: C7ESKJ8FU1Z7
• CAGE: 96K43
Overview
Awardee Type
Parent
Federal Capability Statement
Alimetrix is a diagnostic laboratory which specializes in the diagnosis of infectious diseases by microarray based polymerase chain reaction (PCR) and next generation sequencing (NGS) technology and . Our methods are able to detect DNA and RNA from bacteria, mycobacteria, fungi, unicellular parasites, and multicellular parasites from both body fluids and tissue. We are able to antimicrobial detect resistance genes to antibacterial, antifungal, and antiviral agents. We are also able to detect genes coding for microbial virulence factors. Our technology is easily modifiable to oncology applications looking for human genes .
Keywords
PCR, NGS, Microarray, Infectious disease, microbiology, bacteria, fungi, virus, parasite, antimicrobial resistance, microbial viruklence
Website
Headquarters
Huntsville, AL
United States
United States
Federal recipient
ALIMETRIX, INC.
(UEI C7ESKJ8FU1Z7, CAGE 96K43)
is headquartered in Huntsville AL.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in September 2015 and
federally registered in
October 2021.
Federal Registration and Certifications
Legal Name
ALIMETRIX, INC.
UEI
C7ESKJ8FU1Z7
CAGE Code
96K43
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Sept. 2, 2015
Initial Registration
Oct. 6, 2021
Last Registration
June 9, 2023
Registration Activation
June 9, 2022
Registration Expiration
June 9, 2023
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Disaster Registry
Nationwide
Reported NAICS
Accepts Credit Cards
Yes